Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Rivastigmine 1 A Pharma“
Suchtreffer
Begriffe & Kennungen
Rivastigmine 1 A Pharma · 4.8 · Nervous system disorders Very common Dizziness Common Headache Common Somnolence Common Tremor Uncommon Syncop
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Pre-defined adverse events that may reflect Rivastigmine Placebo worsening of parkinsonian symptoms in n (%) n
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Pre-defined adverse events that may reflect Rivastigmine Placebo worsening of parkinsonian symptoms in n (%) n
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Psychiatric disorders Common Agitation Common Confusion Common Anxiety Common Nightmares Uncommon Insomnia Unc
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Psychiatric disorders Common Insomnia Common Anxiety Common Restlessness Common Hallucination, visual Common D
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Summary of the safety profile The most commonly reported adverse reactions (ADRs) are gastrointestinal, includ
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Summary of the safety profile The most commonly reported adverse reactions (ADRs) are gastrointestinal, includ
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Table 2 shows the adverse reactions reported in patients with dementia associated with Parkinson’s disease tre
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Table 2 shows the adverse reactions reported in patients with dementia associated with Parkinson’s disease tre
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with ri
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with ri
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Tabulated list of adverse reactions Adverse reactions in Table 1 and Table 2 are listed according to MedDRA sy
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · Tabulated list of adverse reactions Adverse reactions in Table 1 and Table 2 are listed according to MedDRA sy
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · The following additional adverse reaction has been observed in a study of patients with dementia associated wi
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · The following additional adverse reaction has been observed in a study of patients with dementia associated wi
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · The following additional adverse reactions have been observed with rivastigmine transdermal patches: delirium,
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · The following additional adverse reactions have been observed with rivastigmine transdermal patches: delirium,
Eintrag öffnenRivastigmine 1 A Pharma · 4.8 · The following adverse reactions, listed below in Table 1, have been accumulated in patients with Alzheimer’s d
Eintrag öffnen